Skip to content
ppharmaranks
Menu

CIBINQO vs RINVOQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. CIBINQO and RINVOQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

64/100
72/100

Pharmacy pays

Type

RX
RX

Active ingredient

ABROCITINIB
UPADACITINIB

Manufacturer

Dosage forms

Tablet
Solution, Tablet, extended release

Drug class

Janus Kinase Inhibitor
Janus Kinase Inhibitor

Half-life

about 8 to 14 hours (mean terminal elimination half-life)

Treats

Atopic Dermatitis
Rheumatoid Arthritis

Frequently asked questions

Which is better-rated, Cibinqo or Rinvoq?

By our independent rating, Rinvoq scores higher — 3.6 vs 3.2 out of 5 for Cibinqo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Cibinqo and Rinvoq?

Cibinqo contains Abrocitinib, while Rinvoq contains Upadacitinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.